Cytoxan (CTX), adriamycin (ADR) and cis platinum (CDDP) infusion (CAP-II) in patients with advanced large cell (LGC) lung cancer

R. T. Eagan, J. N. Ingle, S. Frytak, J. Rubin

Research output: Contribution to journalArticlepeer-review

4 Scopus citations
Original languageEnglish (US)
Pages (from-to)No. 311
JournalProceedings of the American Association for Cancer Research
VolumeVol. 19
StatePublished - 1978

ASJC Scopus subject areas

  • General Medicine

Cite this